Biotech

All Articles

Sanofi pays for $110M upfront for late-stage radioligand treatment

.Sanofi has actually made a late entrance to the radioligand gathering, paying 100 million euros ($ ...

F 2G rears $100M for 2nd effort to get brand new antifungal to market

.After F2G's very first try to obtain a brand-new course of antifungal to market was actually thwart...

Moderna targets $1.1 B in R&ampD investing slices, drops 5 plans among earnings pressures

.Moderna has actually promised to cut R&ampD spending through $1.1 billion through 2027. The selecti...

Sanofi's $80M bet on Fulcrum dystrophy medication ends in stage 3 go bust

.Only four months after Sanofi bet $80 million in beforehand cash money on Fulcrum Therapies' losmap...

Oncternal assets drains 60% amid layoffs, trial discontinuations

.Cancer cells business Oncternal Therapeutics is folding all its own professional trials as well as ...

Roche is holding out chances that its injectable excessive weight possibility might ultimately display 25% weight reduction in late-stage test

.Roche is holding out chances that its own injectable being overweight possibility could ultimately ...

Novo Nordisk barrages 'remarkable' fat burning result for dual-acting oral drug in early test

.Novo Nordisk has actually elevated the top on a phase 1 test of its own dental amylin and GLP-1 rec...

AbbVie files suit BeiGene over blood stream cancer cells medication classified information

.Merely a couple of quick full weeks after winning an FDA Fast lane tag for its own investigational ...

Lilly provides one-two strike along with 2nd tranche of positive records on once a week insulin candidate

.Shortly after a beneficial records drop for Eli Lilly's efsitora alfa, the Indianapolis-based busin...

BridgeBio reduces genetics treatment budget plan as clinical records dissatisfy

.BridgeBio Pharma is lowering its own genetics treatment budget and also pulling back from the techn...